DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Election/Restrictions
Claims 5-19 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 05/18/2026.
Claim Objections
Claims 1-4 are objected to because of the following informalities: The brackets around the claim numbering should be removed. [Claim 1] should reach Claim 1. Appropriate correction is required.
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claim(s) 1-4 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Gatineau et al. (US 2016/002786).
As to claim 1, Gatineau et al. disclose a molybdenum precursor compound represented by formulas 1 and 2 (see Mo(NtAmyl)2 (NHtAmyl)2 of claim 11).
As to claim 3, Gatineau et al. discloses the same precursor as being claimed, Mo(NtAmyl)2 (NHtAmyl)2. Applicant states this precursor has a TG50 of 204.1 (see paragraph 163 and Table 1 of the specification dated 03/07/2025), therefore the compound of Gatineau meets the claimed limitation.
As to claim 4, Gatineau et al. discloses the same precursor as being claimed, Mo(NtAmyl)2 (NHtAmyl)2. Applicant states this precursor has a residual weight at 500 C of 0% to 1.3% relative to an initial weight of 10 mg (see 0164 of the specification). This would equate to a residual weight of 87-100%, where W25 of 10 mg and W500 or 0-1.3 mg.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to Cachet I Proctor whose telephone number is (571)272-0691. The examiner can normally be reached Monday-Friday 7-3 pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Cleveland can be reached at 571-272-1418. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/CACHET I. PROCTOR/
Examiner
Art Unit 1712
/CACHET I PROCTOR/ Primary Examiner, Art Unit 1712
Prosecution Insights